CliffBio
small molecule

DICYCLOMINE HYDROCHLORIDE

DICYCLOMINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyNovitium Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand nameDICYCLOMINE HYDROCHLORIDE
Active ingredientDICYCLOMINE HYDROCHLORIDE
Strength10MG/5ML
Dosage formSYRUP
RouteORAL
ModalitySmall molecule
FDA approvalApril 2021
Marketing statusRX

More from Novitium Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.